Big data firm GNS Healthcare said Wednesday it has closed a $10 million funding round that will help it double in size this year.
The Cambridge company uses vast amounts of health care data to help identify the causes of diseases and predict which treatments will be effective for patient groups and individuals. GNS models are used by physicians, insurers, and drug makers.
The new round included funding from series A investor Cambia Health Solutions, plus financing from new investors Mitsui Company and the Heritage Provider Network.
“Our work with leading pharmaceutical companies, health plans, and providers continues to demonstrate the enormous potential that big data has to create value in all areas of health care,” said Colin Hill, chief executive of GNS Healthcare. “With the help of Cambia, Heritage, and Mitsui USA, we will continue to provide health care stakeholders with models and products that will improve outcomes while decreasing health care costs.”